Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Chief Legal Officer | October 01, 2026 | October 03, 2026 |
| TALPHERA, INC.ACRX · Entity 7102 | General Counsel and Secretary | April 16, 2018 | April 18, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,348 |
Ending reported balance
After 2026-10-01 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-10-01 · Exercise / conversion · Acquired 974 · Balance 39,965 Row 2 · 2026-10-01 · Exercise / conversion · Acquired 1,668 · Balance 41,633 Row 3 · 2026-10-01 · Exercise / conversion · Acquired 2,925 · Balance 44,558 Row 4 · 2026-10-01 · Exercise / conversion · Acquired 1,496 · Balance 46,054 Row 5 · 2026-10-01 · Tax withholding · Disposed 3,706 · Balance 42,348 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-10-01 · Exercise / conversion · Disposed 974 · Balance 0 F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-10-01 · Exercise / conversion · Disposed 1,668 · Balance 0 F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 11,701 |
Reported balance
After 2026-10-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-10-01 · Exercise / conversion · Disposed 2,925 · Balance 11,701 F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 8,978 |
Reported balance
After 2026-10-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-10-01 · Exercise / conversion · Disposed 1,496 · Balance 8,978 F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter.
F3: Not applicable for Restricted Stock Units.
F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter.
F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
TALPHERA, INC.
Report date April 16, 2018 · Filed April 18, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.40 · Expires 2028-04-16 | Direct | 145,000 |
Reported balance
After 2018-04-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-04-16 · Grant · Acquired 145,000 · Balance 145,000 F1: Issued pursuant to the 2011 Equity Incentive Plan. F2: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. |
Filing footnotes · ownership attribution and instrument terms
F1: Issued pursuant to the 2011 Equity Incentive Plan.
F2: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
WAGEWORKS, INC.
Report date August 30, 2019 · Filed August 30, 2019
Section 16 reporting ended · disclosed 2019-08-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-08-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-08-30 · Disposition to issuer · Disposed 29,212 · Balance 0 F1: At the effective time of the merger, this equity grant was converted into RSUs of the acquiring company. |
Filing footnotes · ownership attribution and instrument terms
F1: At the effective time of the merger, this equity grant was converted into RSUs of the acquiring company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2025 Filed Mar 4, 2025 23:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000062 · wk-form4_1741130180.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 5,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000062 · wk-form4_1741130180.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 23:02 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000018 · wk-form4_1735945322.xml · derivative · entry 5 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,671 Underlying: Common Stock · 1,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 23:02 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 974 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000018 · wk-form4_1735945322.xml · derivative · entry 4 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,818 Underlying: Common Stock · 974 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 23:02 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,500 | $30.55 | $45,825.00 |
DisclosureSEC source: 0001576280-25-000018 · wk-form4_1735945322.xml · nonDerivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,701 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 23:02 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000018 · wk-form4_1735945322.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 23:02 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 974 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000018 · wk-form4_1735945322.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2024 Filed Dec 16, 2024 23:28 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,020 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000313 · wk-form4_1734391679.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,117 Underlying: Common Stock · 1,020 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 15, 2024 Filed Dec 16, 2024 23:28 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 535 | $34.76 | $18,596.60 |
DisclosureSEC source: 0001576280-24-000313 · wk-form4_1734391679.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,560 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 15, 2024 Filed Dec 16, 2024 23:28 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000313 · wk-form4_1734391679.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 00:27 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 263 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000295 · wk-form4_1733185640.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 790 Underlying: Common Stock · 263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vested as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award vest in equal installments on each quarterly anniversary of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 00:27 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 138 | $35.61 | $4,914.18 |
DisclosureSEC source: 0001576280-24-000295 · wk-form4_1733185640.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,075 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 00:27 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000295 · wk-form4_1733185640.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 23:16 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 34,926 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000277 · wk-form4_1731453409.xml · derivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,926 Underlying: Common Stock · 34,926 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 23:16 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 52,389 | $0.00 Strike: $28.61 | $0.00 |
DisclosureSEC source: 0001576280-24-000277 · wk-form4_1731453409.xml · derivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,389 Underlying: Common Stock · 52,389 shares Expires 2034-11-08 F1 · derivative.exercise_date: This represents a stock option award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:56 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 6,569 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000242 · wk-form4_1727902563.xml · derivative · entry 5 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,338 Underlying: Common Stock · 6,569 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:56 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 974 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000242 · wk-form4_1727902563.xml · derivative · entry 4 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,792 Underlying: Common Stock · 974 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:56 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 3,824 | $22.12 | $84,586.88 |
DisclosureSEC source: 0001576280-24-000242 · wk-form4_1727902563.xml · nonDerivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,950 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:56 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 6,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000242 · wk-form4_1727902563.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:56 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 974 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000242 · wk-form4_1727902563.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,205 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2024 Filed Sep 16, 2024 21:33 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,019 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000222 · wk-form4_1726522393.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,137 Underlying: Common Stock · 1,019 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 15, 2024 Filed Sep 16, 2024 21:33 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 517 | $26.79 | $13,850.43 |
DisclosureSEC source: 0001576280-24-000222 · wk-form4_1726522393.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,231 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 15, 2024 Filed Sep 16, 2024 21:33 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000222 · wk-form4_1726522393.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,748 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2024 Filed Sep 10, 2024 21:01 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 443 | $23.77 | $10,530.11 |
DisclosureSEC source: 0001576280-24-000210 · wk-form4_1726002091.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,729 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 20:47 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 263 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000202 · wk-form4_1725396461.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,053 Underlying: Common Stock · 263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 20:47 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 134 | $28.58 | $3,829.72 |
DisclosureSEC source: 0001576280-24-000202 · wk-form4_1725396461.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,172 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 20:47 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000202 · wk-form4_1725396461.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:58 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 974 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000172 · wk-form4_1719953898.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,766 Underlying: Common Stock · 974 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:58 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 348 | $28.26 | $9,834.48 |
DisclosureSEC source: 0001576280-24-000172 · wk-form4_1719953898.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,043 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:58 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 974 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000172 · wk-form4_1719953898.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:43 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 4,017 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000154 · wk-form4_1718664217.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,156 Underlying: Common Stock · 4,017 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:43 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,434 | $30.21 | $43,321.14 |
DisclosureSEC source: 0001576280-24-000154 · wk-form4_1718664217.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,417 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:43 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 4,017 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000154 · wk-form4_1718664217.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 22:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 263 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000128 · wk-form4_1717453521.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,316 Underlying: Common Stock · 263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 22:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 94 | $27.10 | $2,547.40 |
DisclosureSEC source: 0001576280-24-000128 · wk-form4_1717453521.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,834 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 22:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000128 · wk-form4_1717453521.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2024 Filed Apr 16, 2024 22:35 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 7,569 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000092 · wk-form4_1713306910.xml · derivative · entry 4 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,137 Underlying: Common Stock · 7,569 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units granted on August 8, 2022 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of April 15, 2022, and the remaining 75% annually during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 15, 2024 Filed Apr 16, 2024 22:35 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 2,701 | $17.06 | $46,079.06 |
DisclosureSEC source: 0001576280-24-000092 · wk-form4_1713306910.xml · nonDerivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,665 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| April 15, 2024 Filed Apr 16, 2024 22:35 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 7,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000092 · wk-form4_1713306910.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2024 Filed Apr 16, 2024 22:35 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,108 | $17.06 | $18,902.48 |
DisclosureSEC source: 0001576280-24-000092 · wk-form4_1713306910.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,797 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:09 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 974 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000086 · wk-form4_1712095787.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,740 Underlying: Common Stock · 974 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:09 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 400 | $20.25 | $8,100.00 |
DisclosureSEC source: 0001576280-24-000086 · wk-form4_1712095787.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,905 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:09 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 974 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000086 · wk-form4_1712095787.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 23:39 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 263 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000055 · wk-form4_1709595522.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,579 Underlying: Common Stock · 263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 23:39 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 108 | $18.97 | $2,048.76 |
DisclosureSEC source: 0001576280-24-000055 · wk-form4_1709595522.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,331 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 23:39 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000055 · wk-form4_1709595522.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:51 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 974 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000014 · wk-form4_1704329455.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,714 Underlying: COMMON STOCK · 974 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:51 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 400 | $27.05 | $10,820.00 |
DisclosureSEC source: 0001576280-24-000014 · wk-form4_1704329455.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,176 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:51 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 974 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000014 · wk-form4_1704329455.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:26 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 19,907 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000219 · wk-form4_1702679178.xml · derivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,907 Underlying: COMMON STOCK · 19,907 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.